BCM
PRME icon

Bridgeway Capital Management’s Prime Medicine PRME Stock Holding History

Bridgeway Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Sell
64,800
-70,000
-52% -$232K ﹤0.01% 1022
2026
Q1 		$469K Hold
134,800
– – 0.01% 833
2025
Q4 		$468K Sell
134,800
-30,000
-18% -$133K 0.01% 835
2025
Q3 		$913K Sell
164,800
-50,000
-23% -$203K 0.02% 713
2025
Q2 		$531K Buy
+214,800
New +$331K 0.01% 769

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Bridgeway Capital Management's PRME Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Prime Medicine (PRME) stake by 52% in Q2 2026, selling an estimated $232K and leaving 64,800 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #1022.

Bridgeway Capital Management first reported a position in PRME in Q2 2025 and has held it in 5 quarters since. The position peaked at $913K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Bridgeway Capital Management held 64,800 shares of Prime Medicine worth $239K as of Q2 2026.
  • Bridgeway Capital Management sold 70,000 Prime Medicine shares in Q2 2026, an estimated $232K.
  • Prime Medicine made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1022 holding.
  • Bridgeway Capital Management first reported a position in Prime Medicine in Q2 2025 and has held it in 5 quarters since.
  • Bridgeway Capital Management's Prime Medicine position peaked at $913K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.